Cannabis, botanically derived extracts or derivatives of cannabis and tetrahydrocannabinols (THCs) where they are botanically derived from cannabis have been scheduled for human therapeutic use by the Therapeutic Goods Administration, paving the way for broader availability of medical marijuana.
The products must be produced or manufactured in accordance with the Narcotic Drugs Act 1967 or imported in accordance with the Customs (Prohibited Imports) Regulations 1956.
Visit www.tga.gov.au for details.
The above article was sent to subscribers in Pharmacy Daily's issue from 02 Sep 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Sep 16
